Proin Er is a drug owned by PEGASUS LABORATORIES, INC. It is protected by 1 US drug patent filed in 2031. All patents are active. Details of Proin Er’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US9248096 | Active | |
Exclusivity Information
Proin Er holds 1 exclusivity out of which 1 has expired. Details of Proin Er's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Mar 29, 2022 |
About Proin Er
Proin Er is a drug
owned by PEGASUS LABORATORIES, INC.
Proin Er uses
Phenylpropanolamine Hydrochloride as the active
ingredient.
Active Ingredient:
Proin Er uses
Phenylpropanolamine Hydrochloride as the active ingredient.
Check out other Drugs and Companies using
Phenylpropanolamine Hydrochloride ingredient.